C1orf105
Basic information
Region (hg38): 1:172420684-172468831
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (32 variants)
- Glycosylphosphatidylinositol biosynthesis defect 16 (14 variants)
- Inborn genetic diseases (10 variants)
- Non-immune hydrops fetalis (1 variants)
- Global developmental delay (1 variants)
- not specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C1orf105 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 1 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 28 | 45 | ||||
Total | 1 | 4 | 29 | 8 | 4 |
Highest pathogenic variant AF is 0.00000657
Variants in C1orf105
This is a list of pathogenic ClinVar variants found in the C1orf105 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-172441758-T-G | not specified | Uncertain significance (Aug 30, 2022) | ||
1-172441762-T-C | Likely benign (Feb 01, 2023) | |||
1-172441764-C-A | Glycosylphosphatidylinositol biosynthesis defect 16 | Pathogenic (Nov 29, 2022) | ||
1-172441773-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
1-172441811-C-T | Glycosylphosphatidylinositol biosynthesis defect 16 | Uncertain significance (Dec 28, 2022) | ||
1-172441827-G-A | Glycosylphosphatidylinositol biosynthesis defect 16 | Benign (Jan 31, 2024) | ||
1-172441884-T-C | Glycosylphosphatidylinositol biosynthesis defect 16 | Uncertain significance (Nov 15, 2018) | ||
1-172441947-G-A | Benign/Likely benign (Mar 01, 2024) | |||
1-172441964-A-G | Non-immune hydrops fetalis • Glycosylphosphatidylinositol biosynthesis defect 16 | Conflicting classifications of pathogenicity (Mar 17, 2024) | ||
1-172441979-A-G | Uncertain significance (Oct 01, 2022) | |||
1-172441988-A-C | not specified | Uncertain significance (Feb 27, 2024) | ||
1-172441988-A-G | Glycosylphosphatidylinositol biosynthesis defect 16 | Likely pathogenic (Oct 15, 2018) | ||
1-172442039-C-T | Uncertain significance (Aug 02, 2022) | |||
1-172442049-G-A | Glycosylphosphatidylinositol biosynthesis defect 16 | Uncertain significance (Jan 09, 2024) | ||
1-172442057-A-C | Glycosylphosphatidylinositol biosynthesis defect 16 | Likely pathogenic (Oct 15, 2018) | ||
1-172442066-G-C | not specified | Uncertain significance (Sep 24, 2021) | ||
1-172442090-G-A | Uncertain significance (Oct 04, 2022) | |||
1-172442092-T-C | Likely benign (Apr 27, 2023) | |||
1-172442093-A-G | Uncertain significance (Dec 07, 2023) | |||
1-172442125-A-G | Benign (Dec 12, 2023) | |||
1-172442178-T-C | not specified | Uncertain significance (Jun 13, 2022) | ||
1-172442212-C-T | Likely benign (Oct 25, 2022) | |||
1-172442230-A-G | Likely benign (Sep 19, 2023) | |||
1-172442234-G-A | Glycosylphosphatidylinositol biosynthesis defect 16 | Uncertain significance (Feb 27, 2022) | ||
1-172442287-A-G | Likely benign (Jun 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C1orf105 | protein_coding | protein_coding | ENST00000367727 | 7 | 48144 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000110 | 0.371 | 111498 | 599 | 13630 | 125727 | 0.0583 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.350 | 84 | 93.5 | 0.898 | 0.00000443 | 1199 |
Missense in Polyphen | 8 | 6.002 | 1.3329 | 69 | ||
Synonymous | 0.859 | 27 | 33.3 | 0.811 | 0.00000166 | 332 |
Loss of Function | 0.295 | 8 | 8.95 | 0.894 | 3.77e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0667 | 0.0659 |
Ashkenazi Jewish | 0.0965 | 0.0942 |
East Asian | 0.00104 | 0.000489 |
Finnish | 0.118 | 0.116 |
European (Non-Finnish) | 0.0655 | 0.0638 |
Middle Eastern | 0.00104 | 0.000489 |
South Asian | 0.0684 | 0.0635 |
Other | 0.0751 | 0.0729 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.784
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 85.98
Haploinsufficiency Scores
- pHI
- 0.0532
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- 4930558K02Rik
- Phenotype
Gene ontology
- Biological process
- Cellular component
- Molecular function
- protein binding